573 related articles for article (PubMed ID: 26938930)
1. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).
Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B
Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930
[TBL] [Abstract][Full Text] [Related]
2. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
[TBL] [Abstract][Full Text] [Related]
4. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.
Yao H; Jiang F; Hu H; Gao Y; Zhu Z; Zhang H; Wang Y; Guo Y; Liu L; Yuan Y; Zhou L; Wang J; Du B; Qu N; Zhang R; Dong Y; Xu H; Chen F; Jiang H; Liu Y; Zhang L; Tian Z; Liu Q; Zhang C; Pan X; Yang S; Zhao L; Wang W; Liang Z
Ultrasound Obstet Gynecol; 2014 Jul; 44(1):17-24. PubMed ID: 24616044
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
6. Women should decide which conditions matter.
Norton ME; Kuppermann M
Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793311
[TBL] [Abstract][Full Text] [Related]
7. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
[TBL] [Abstract][Full Text] [Related]
10. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?
Mennuti MT; Cherry AM; Morrissette JJ; Dugoff L
Am J Obstet Gynecol; 2013 Nov; 209(5):415-9. PubMed ID: 23529082
[TBL] [Abstract][Full Text] [Related]
11. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon.
Yaron Y
Prenat Diagn; 2016 May; 36(5):391-6. PubMed ID: 26941176
[TBL] [Abstract][Full Text] [Related]
12. Fetal aneuploidy screening with cell-free DNA in late gestation.
Taneja PA; Prosen TL; de Feo E; Kruglyak KM; Halks-Miller M; Curnow KJ; Bhatt S
J Matern Fetal Neonatal Med; 2017 Feb; 30(3):338-342. PubMed ID: 27124739
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study.
Nishiyama M; Sekizawa A; Ogawa K; Sawai H; Nakamura H; Samura O; Suzumori N; Nakayama S; Yamada T; Ogawa M; Katagiri Y; Murotsuki J; Okamoto Y; Namba A; Hamanoue H; Ogawa M; Miura K; Izumi S; Kamei Y; Sago H
Prenat Diagn; 2016 Dec; 36(12):1121-1126. PubMed ID: 27760457
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
15. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
Wagner AJ; Mitchell ME; Tomita-Mitchell A
Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
[TBL] [Abstract][Full Text] [Related]
16. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal testing.
Lo JO; Cori D F; Norton ME; Caughey AB
Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
20. Open source non-invasive prenatal testing platform and its performance in a public health laboratory.
Johansen P; Richter SR; Balslev-Harder M; Miltoft CB; Tabor A; Duno M; Kjaergaard S
Prenat Diagn; 2016 Jun; 36(6):530-6. PubMed ID: 27027563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]